Total expenditure on drugs to treat hypertension in Italy 2022, by type
In 2022, the total public expenditure on drugs to treat hypertension and cardiac decompensation in Italy was equal to over two billion euros. This statistic breaks down this figure by category of the drugs. According to the data, the spending for beta blockers amounted to over 335 million euros, while the expenses for calcium channel blockers (dihydropyridine) reached roughly 242 million euros during the year under consideration.
